What is this thing called pain?

Journal of Clinical Investigation

Volumn 120, Issue 11, 2010, Pages 3742-3744

  Woolf, Clifford J ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; PROTEIN TYROSINE KINASE A; SODIUM CHANNEL NAV1.7; VANILLOID RECEPTOR 1;

ANALGESIA (SENSORY DYSFUNCTION); AUTONOMIC NEUROPATHY; DISEASE CLASSIFICATION; GENE DELETION; HUMAN; LOSS OF FUNCTION MUTATION; MISSENSE MUTATION; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW;

HUMANS; PAIN; SYNDROME;

EID: 78049433957     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI45178     Document Type: Review

References (19)

1. Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009;139(2):267-284.
2. Raouf R, Quick K, Wood JN. Pain as a channelopathy. J Clin Invest. 2010;120(11):3745-3752.
3. Reilly MM, Shy ME. Diagnosis and new treatments in genetic neuropathies. J Neurol Neurosurg Psychiatry. 2009;80(12):1304-1314.
4. Haus BM, Hsu AR, Yim ES, Meter JJ, Rinsky LA. Long-term follow-up of the surgical management of neuropathic arthropathy of the spine. Spine J. 2010;10(6):e6-e16.
5. Mabilleau G, Edmonds ME. Role of neuropathy on fracture healing in Charcot neuro-osteoarthropathy. J Musculoskelet Neuronal Interact. 2010;10(1):84-91.
6. Burgess G, Williams D. The discovery and development of analgesics: new mechanisms, new modalities. J Clin Invest. 2010;120(11):3753-3759.
7. Clark JD. The pitfalls of profoundly effective analgesic therapies. Clin J Pain. 2008;24(9):825-831.
8. Dubin AE, Patapoutian A. Nociceptors: the sensors of the pain pathway. J Clin Invest. 2010;120(11):3760-3772.
9. Ma Q. Labeled lines meet and talk: population coding of somatic sensations. J Clin Invest. 2010;120(11):3773-3778.
10. Ossipov MH, Dussor GO, Porreca F. Central modulation of pain. J Clin Invest. 2010;120(11):3779-3787.
11. Petrovic P, Kalso E, Petersson KM, Andersson J, Fransson P, Ingvar M. A prefrontal non-opioid mechanism in placebo analgesia. Pain. 2010;150(1):59-65.
12. Wager TD, Scott DJ, Zubieta JK. Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci U S A. 2007;104(26):11056-11061.
13. Hayashida K, Eisenach JC. Spinal alpha 2-adrenoceptor-mediated analgesia in neuropathic pain reflects brain-derived nerve growth factor and changes in spinal cholinergic neuronal function. Anesthesiology. 2010;113(2):406-412.
14. Schweinhardt P, Bushnell MC. Pain imaging in health and disease - how far have we come? J Clin Invest. 2010;120(11):3788-3797.
15. Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci. 2009;32:1-32.
16. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895-926.
17. Williams FM, Spector TD, MacGregor AJ. Pain reporting at different body sites is explained by a single underlying genetic factor. Rheumatology (Oxford). 2010;49(9):1753-1755.
18. Hartvigsen J, et al. Heritability of spinal pain and consequences of spinal pain: a comprehensive genetic epidemiologic analysis using a population-based sample of 15,328 twins ages 20-71 years. Arthritis Rheum. 2009;61(10):1343-1351.
19. Costigan M, et al. Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1. Brain. 2010;133(9):2519-2527.